Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
SGLT2 inhibitors reduce dementia, Parkinson’s disease risk: study
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk for dementia and Parkinson’s disease, a new study finds.
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Diabetes Medications May Lower Risk of Dementia and Parkinson's Disease
A recent study suggests that a class of diabetes medications could be linked to a reduced risk of developing dementia an..|News Track
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
SGLT2 inhibitors tied to lower risk of dementia, Parkinson's disease, suggests study
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology®,
Medscape
12d
Do SGLT2 Inhibitors Benefit Everyone With T2D and CKD?
New data suggest that current recommendations overstate the proportion of patients who would receive significant kidney ...
Daily
11d
Study Reveals Significant Care Gap in SGLT2 Inhibitor Use for Diabetes and HF, Despite Real-World Benefits
Recent study highlights a significant care gap due to the underuse of SGLT2 inhibitors, despite their benefits. Canada: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Alabama mass shooting
On running again in 2028
Daylight saving time
Ga. suspect's mom indicted
Actress Crosby dies at 90
To skip Al Smith dinner
CAH sues for trespassing
Biden hosts 'Quad' summit
Free COVID-19 tests
Suns broadcaster dies
San Francisco homelessness
House repeals emission rules
No. 1 at box office again
Former WA governor dies
CA firefighter held for arson
ISR raids Al Jazeera office
Donlon's homes searched
Released after guilty plea
J&J unit files for bankruptcy
CA bill to protect kids online
Pandas leaving for China
TN abortion law blocked
Drug price challenge revived
FDA approves flu vaccine
Beirut strike death toll
Boeing defense chief exits
Iran coal mine blast
SC 1st execution in 13 years
Hezbollah rockets hit Israel
Sesame Place suit verdict
ISR strike on Gaza school
PM Modi visits US
Feedback